Skip to main content
SpringerLink
Log in

Correlation analysis between serum β2-MG and sodium/iodide symporter in patients with thyroid carcinoma

  • Published:
The Chinese-German Journal of Clinical Oncology

Abstract

Objective

The aim of our study was to investigate the correlation between the expression of sodium/iodide symporter, serum levels of β2-MG and prognosis of thyroid carcinoma patients.

Methods

Ninty-five cases with thyroid carcinoma, using enzyme-linked immunosorbent assay with double-antibody sandwich to detect the serum β2-MG levels and immunohistochemistry to detect NIS expression of thyroid cancer tissue.

Results

Thirty-seven cases showed positive expression of sodium/iodide symporter (38.9%) and 30 cases showed positive expression of β2-MG (31.57%). There were significant differences of NIS expression (χ2 = 8.207, P = 0.017) and β2-MG expression (χ2 = 10.121, P = 0.006) between different pathological types of thyroid carcinoma, but there was no correlation between the positive rate of the two research groups (r = −0.546, P = 0.633). The significant differences was observed in expression of sodium/iodide symporter (χ2 = 9.272, P=0.002) and expression of β2-MG (χ2 = 4.441, P = 0.035) between the group with neck lymph node metastasis and the group without neck lymph node metastasis and both positive rate was significantly negatively correlated (r = −1.000, P = 0.000). The significant differences was observed in expression of sodium/iodide symporter (χ2 = 9.272, P = 0.002) and expression of β2-MG (χ2 = 3.867, P = 0.043) between the group with distant organ metastasis and the group without distant organ metastasis (χ2 = 11.985, P = 0.001) and both positive rate was significantly negatively correlated (r = −1.000, P = 0.000).

Conclusion

There are significantly negatively correlated between neck lymph node metastasis, distant organ metastasis and expression of sodium/iodide symporter and expression of β2-MG. Thyroid cancer lymph node and distant organ metastasis, the tumor tissue NIS expression and serum levels of β2-MG is significantly negatively correlated. The detection of serum β2-MG provides clinical reference value for the effects on radionuclide therapy and prognosis assessment of thyroid carcinoma. Serum β2-MG levels is negatively correlated with prognosis in thyroid cancer patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Yu GP, Li JC, Branovan D, et al. Thyroid cancer incidence and survival in the national cancer institute surveillance, epidemiology, and end results race/ethnicity groups. Thyroid, 2010, 20: 465–473.

    Article  PubMed  Google Scholar 

  2. Li HP, Liu QJ, Dong F. Clinical study on radiofrequency combined with 131I therapy for dedifferentiated thyroid carcinomas. Chinese-German J Clinl Oncol, 2011, 10: 274–277.

    Article  CAS  Google Scholar 

  3. Ma SH, Liu QJ, Li KS. The clinical significance evaluation of serum β2-microglobulin for thyroid cancer patients. Chinese-German J Clin Oncol, 2012, 11: 271–273.

    Article  CAS  Google Scholar 

  4. Du HF, Li KS, Lian XW, et al. Production and identification of monoclonal antibodies against β2-microglobulin. Chin Med Her (Chinese), 2008, 4: 36–37.

    Google Scholar 

  5. Sodré AK, Rubio IG, Galrão AL, et al. Association of low sodium-Iodide symporter messenger ribonucleic acid expression in malignant thyroid nodules with increased intracellular protein staining. J Clin Endocrinol Metab, 2008, 93: 4141–4145.

    Article  PubMed  Google Scholar 

  6. Li W, Ain KB. Human sodium-iodide symporter (hNIS) gene expression is inhibited by a trans-active transcriptional repressor, NIS-repressor, containing PARP-1 in thyroid cancer cells. Endocr Relat Cancer, 2010, 17: 383–398.

    Article  PubMed  CAS  Google Scholar 

  7. Josson S, Nomura T, Lin JT, et al. β2-microglobulin induces epithelial to mesenchymal transition and confers cancer lethality and bone metastasis in human cancer cells. Cancer Res, 2011, 71: 2600–2610.

    Article  PubMed  CAS  Google Scholar 

  8. Chen CH, Su CY, Chien CY, et al. Overexpression of beta2-microglobulin is associated with poor survival in patients with oral cavity squamous cell carcinoma and contributes to oral cancer cell migration and invasion. Br J Cancer, 2008, 99: 1453–1461.

    Article  PubMed  CAS  Google Scholar 

  9. Smith VE, Read ML, Turnell AS, et al. A novel mechanism of sodium iodide symporter repression in differentiated thyroid cancer. J Cell Sci, 2009, 122: 3393–3402.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Gansu Province Tumor Hospital, Lanzhou, 730050, China

    Xiaofeng Hou, Qinjiang Liu & Shihong Ma

Authors
  1. Xiaofeng Hou
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Qinjiang Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Shihong Ma
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Qinjiang Liu.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hou, X., Liu, Q. & Ma, S. Correlation analysis between serum β2-MG and sodium/iodide symporter in patients with thyroid carcinoma. Chin. -Ger. J. Clin. Oncol. 12, 65–67 (2013). https://doi.org/10.1007/s10330-012-1123-5

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10330-012-1123-5

Key words

Search

Navigation